Loading clinical trials...
Loading clinical trials...
Effects of Graded Repetitive Arm Supplementary Program Versus Task Based Training on Upper Limb Function in Stroke Patients
To determine effects of graded repetitive arm supplementary program versus Task based training on Upper limb function in stroke patients.
This study will be Randomized Clinical Trial. A total of 38 stroke patients will be recruited by using non-probability convenience sampling Technique. Patients will be Randomized and allocated into two interventional groups based on the inclusion and exclusion criteria. Patients in Group A will receive Graded repetitive arm supplementary program and Patients in Group B will receive Task based training. All participants will receive the treatment for 40 minutes per session, 5 days per week for 5 weeks. For the evaluation of all participant scales like be Chedoke Arm and Hand Activity Inventory for clinical relevance, Fugl Mayer assessment scale for performance assessment, Action Reach Arm Test for coordination and dexterity and Motor Activity Log for functional assessment of Upper limb in stroke patients. D
Age
40 - 60 years
Sex
ALL
Healthy Volunteers
No
Imran International Amjad
Islamabad, Punjab Province, Pakistan
Start Date
May 1, 2024
Primary Completion Date
September 1, 2024
Completion Date
September 1, 2024
Last Updated
September 19, 2024
38
ACTUAL participants
Graded repetitive arm supplementary program
OTHER
Task based training
OTHER
Lead Sponsor
Riphah International University
NCT06258538
NCT05093673
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07371455